(HEALTH NEWS) Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint inhibitors. Although the adverse event is rare — affecting less than 1% of patients given the immunotherapy — the mortality rate is nearly 50%.
Now, researchers from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation.
The researchers discovered that T-cells recognizing the cardiac antigen α-myosin are the mechanism for this .
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The Mark Foundation for Cancer Research has selected four outstanding scientific research projects to receive $12 million in funding for its.
/PRNewswire/ The Mark Foundation for Cancer Research has selected four outstanding scientific research projects to receive $12 million in funding for its.